Oppilotech and Evariste Technologies Announce Partnership to Develop First-in-Class Antibacterial Programme

London, UK, 16th March 2022 – Oppilotech Ltd, a biotech specialising in systems biology and machine learning platforms to build unique predictive computational models of cells, announces a co-development drug discovery partnership with the UK’s Evariste Technologies, which will use machine learning and artificial intelligence to establish a first-in-class antibacterial programme.

Read the full release here.